Philips Files 6-K Report

TL;DR

Philips filed its 6-K, confirming its Dutch HQ and 20-F filing status.

AI Summary

Koninklijke Philips NV filed a Form 6-K on May 8, 2024, to report its status as a foreign issuer. The filing confirms its principal executive offices are located at Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands. Philips is incorporated in The Netherlands and is subject to the 1934 Act, filing annual reports under Form 20-F.

Why It Matters

This filing is a routine disclosure for foreign issuers, confirming their reporting obligations and principal place of business in the US.

Risk Assessment

Risk Level: low — This is a standard procedural filing for a foreign issuer and does not contain new financial or operational information.

Key Players & Entities

• Koninklijke Philips NV (company) — Registrant
• Royal Philips (company) — Registrant's name in English
• The Netherlands (company) — Jurisdiction of incorporation
• Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (company) — Address of principal executive offices
• May 8, 2024 (date) — Filing date

FAQ

Filing Documents

• phg-20240508.htm (6-K) — 25KB
• visual0001.jpg (GRAPHIC) — 93KB
• visual0002.jpg (GRAPHIC) — 77KB
• 0000313216-24-000009.txt ( ) — 245KB

From the Filing

Philips - 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 8, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission: M.J. van Ginneken Koninklijke Philips N.V. Amstelplein 2 1096 BC Amsterdam – The Netherlands This report comprises a copy of the following press release: “ Philips shareholders approve all proposals at the AGM 2024 ", dated May 7, 2024 . Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on May 8, 2024. KONINKLIJKE PHILIPS N.V. /s/ M.J. van Ginneken (Chief Legal Officer) Press information May 7, 2024 Philips shareholders approve all proposals at the AGM 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re-appointment of Chairman Feike Sijbesma and Peter Löscher as members of the Supervisory Board. The appointment of Benoît Ribadeau-Dumas as member of the Supervisory Board. The appointment of Charlotte Hanneman as member of the Board of Management, with effect from October 1, 2024. The discharge of the members of the Board of Management and members of the Supervisory Board. A full overview of the resolutions taken at the AGM 2024 can be found below. Feike Sijbesma, Chairman of Philips’ Supervisory Board, said: “I am very pleased with the re-appointment of Peter and the appointment of Benoît, who has extensive experience with large and global industrial companies. With our highly knowledgeable and experienced members, the composition of our Supervisory Board is very strong and well positioned to fulfill our vital duty of advising, challenging, and supporting Management in executing Philips’ strategy, and it is an honor to serve a second term leading this Board. I would also like to welcome Charlotte to Philips. She will join Philips’ Board of Management on October 1, and fulfill the role of Chief Financial Officer. Her strong MedTech knowledge and extensive finance experience, coupled with her energy and passion for the healthcare industry, make her an ideal fit for the role. Charlotte will work with Abhijit, Philips’ current Chief Financial Officer, until October, ensuring a smooth transition. I would also like to thank Abhijit in advance for his tremendous contribution to Philips over the last 38 years, and more particularly during his nine years as Chief Financial Officer.” Roy Jakobs, CEO of Royal Philips said: “I want to congratulate our Chairman Feike with his re-appointment. Together with Peter and Benoît, as well as the other Supervisory Board members, they represent the best in the industry to provide oversight and valuable insights to Management in executing Philips’ 2023-2025 plan to create value with sustainable impact for all stakeholders. We look forward to a continued strong and successful collaboration, as we aim to improve the health and well-being of people through meaningful innovation.” All resolutions taken at the AGM 2024: Agenda item Resolution 2 Annual Report 2023 · Adoption of the financial statements 2023 · Adoption of a dividend of EUR 0.85 per common share, in common shares, against retained earnings · Positive advisory vote on the approval of the Remuneration Report 2023 · Discharge of the members of the Board of Management · Discharge of the members of the Supervisory Board 3 Composition of the Board of Management · Appointment of Ms Hanneman as member of the Board of Management with effect from October

View Full Filing

View this 6-K filing on SEC EDGAR